Citation Impact
Citing Papers
Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction
2010
Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib
2008
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Collateral circulation
2008
Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes
2012
EGFR Antagonists in Cancer Treatment
2008 Standout
Vascular Endothelial Growth Factor-C Accelerates Diabetic Wound Healing
2006
Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation
2004 StandoutNature
Sirtuin-7 Inhibits the Activity of Hypoxia-inducible Factors
2013 StandoutNobel
Spermidine/Spermine-N1-Acetyltransferase 2 Is an Essential Component of the Ubiquitin Ligase Complex That Regulates Hypoxia-inducible Factor 1α
2007 StandoutNobel
Local proliferation dominates lesional macrophage accumulation in atherosclerosis
2013
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A
2004
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation
2007
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
A New Weapon for Attacking Tumor Blood Vessels
2008 StandoutNobel
Angiogenesis in health and disease
2003 Standout
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels
2007
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Arteriogenesis versus angiogenesis: similarities and differences
2006
Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia
2009
Angiogenesis in life, disease and medicine
2005 StandoutNature
Analysis and Separation of Residues Important for the Chemoattractant and Antimicrobial Activities of β-Defensin 3
2008 StandoutNobel
Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders
2003
Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling
2010 StandoutNobel
HIF-1 Regulates Cytochrome Oxidase Subunits to Optimize Efficiency of Respiration in Hypoxic Cells
2007 StandoutNobel
Sox18 induces development of the lymphatic vasculature in mice
2008 StandoutNature
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Angiogenic Signalling Pathways
2008
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Vascular Growth in Ischemic Limbs: A Review of Mechanisms and Possible Therapeutic Stimulation
2008
Cancer-related inflammation
2008 StandoutNature
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Regulation of angiogenesis by a non-canonical Wnt–Flt1 pathway in myeloid cells
2011 Nature
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
VEGF‐null cells require PDGFR α signaling‐mediated stromal fibroblast recruitment for tumorigenesis
2004
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
2008
Impairment in Ischemia-Induced Neovascularization in Diabetes
2004
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
2013 StandoutNature
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Angiogenesis
2005
Systemic levels of G-CSF and interleukin-6 determine the angiogenic potential of bone marrow resident monocytes
2010
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Constitutively active HIF-1α improves perfusion and arterial remodeling in an endovascular model of limb ischemia
2005 StandoutNobel
Vascular Endothelial Growth Factor-A Specifies Formation of Native Collaterals and Regulates Collateral Growth in Ischemia
2008
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors
2003 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
2004 StandoutNobel
Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
2003 StandoutNobel
Photoacoustic Tomography: In Vivo Imaging from Organelles to Organs
2012 StandoutScience
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Endothelial Progenitor Cells
2004 Standout
Hypoxia-Inducible Factor-1 Mediates Activation of Cultured Vascular Endothelial Cells by Inducing Multiple Angiogenic Factors
2003
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting
2011
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin
2011 StandoutNobel
Bone Marrow-Derived Cells Do Not Incorporate Into the Adult Growing Vasculature
2003
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
2013 StandoutNobel
Works of Frederic Pipp being referenced
Transplantation of Monocytes: A Novel Strategy for In Vivo Augmentation of Collateral Vessel Growth
2004
VEGFR-1–Selective VEGF Homologue PlGF Is Arteriogenic
2003
The Range of Adaptation by Collateral Vessels After Femoral Artery Occlusion
2006
Blood monocyte concentration is critical for enhancement of collateral artery growth
2002
Elevated Fluid Shear Stress Enhances Postocclusive Collateral Artery Growth and Gene Expression in the Pig Hind Limb
2004